ArticleBMC medical research methodology2026
Bayesian inference of interval-censored data with an application to HIV population surveys: a simulation study comparing Hamiltonian Monte Carlo and Metropolis-Hastings sampling algorithms.
Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundHIV incidence estimation in population-based surveys often relies on interval-censored seroconversion times and complex survey designs, requiring computationally efficient Bayesian methods. We compared the computational efficiency and inferential performance of Hamiltonian Monte Carlo (HMC) and Metropolis-Hastings (MH) for Bayesian analysis of interval-censored HIV seroconversion times using a weighted log-logistic accelerated failure-time model.
methodsWe conducted a simulation study of 5,400 datasets varying sample size, censoring, and weight dispersion under identical likelihoods, priors, diagnostics, and convergence criteria for both samplers, and applied the same model to the Zimbabwe PHIA 2020 survey (ZIMPHIA). Performance was assessed using efficiency (effective sample size per second, ESS/s), accuracy, interval calibration, and standard convergence diagnostics.
resultsHMC delivered substantially higher sampling efficiency across scenarios while producing comparable point estimates, uncertainty, and coverage. On ZIMPHIA ([Formula: see text]), HMC delivered [Formula: see text] higher effective sample size per second than MH for [Formula: see text], equivalent to 1.43 vs 31.83 minutes of wall time at matched effective sample sizes.
conclusionsHMC is a practical default for weighted, interval-censored survival analysis in HIV surveys, with benefits that increase with sample size and weight variability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.